High-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD OutcomesDecember 9, 2024TransplantPatient & Survivor CareALLCLLNon-Hodgkin LymphomaMyelodysplastic SyndromeMixed Topics
Myeloma: Daratumumab Plus Lenalidomide Improves MRD OutcomesSeptember 30, 2024Multiple MyelomaTransplant
No Matched Sibling Donor? Sickle Cell Experts Debate Next-Best OptionSeptember 16, 2024Bleeding DisordersCellular TherapyTransplant
When Childhood Cancer Survivors Face Sexual ChallengesAugust 22, 2024Mixed TopicsPediatricsPatient & Survivor CareALLCMLCLLHodgkin Lymphoma
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024DLBCLGene TherapyMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsPatient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
High Marks for New CAR T Toxicity Grading ToolMarch 12, 2024Cellular TherapyB Cell LymphomaDLBCLMantle Cell LymphomaMultiple MyelomaTransplantMixed Topics
Patient-Reported Outcomes Predict Mortality in Cutaneous Chronic GVHDMarch 1, 2024Mixed TopicsTransplant